The global enterprise imaging IT market is projected to reach USD 4.12 billion by 2030 from USD 2.31 billion in 2025, at a CAGR of 12.2% during the forecast period. Demand is propelled by the shift from capital-heavy license models to cloud native SaaS deployments, which lower upfront costs and accelerate upgrades. The emergence of blockchain-backed image provenance platforms is enhancing data integrity and auditability across multi-vendor ecosystems. Growing medical tourism networks are driving the need for standardized, cross-border image exchange hubs, while the proliferation of point-of-care ultrasound and wearable imaging devices is expanding enterprise workflows to include real-time, bedside acquisitions.
“The diagnostics segment is the fastest-growing segment in the enterprise imaging IT market within the forecast period.”
Based on applications, the enterprise imaging IT market has been divided into diagnostics, therapeutics, and clinical research. The diagnostics segment accounts for the largest share of the enterprise imaging IT market. This segment’s large share and high growth can be attributed to the nationwide rollout of lung cancer screening programs, which has surged low-dose CT volumes and driven enterprise archive demand. The integration of AI-driven triage engines that automatically flag critical findings such as intracranial hemorrhages or pulmonary emboli has also pushed providers to upgrade diagnostic platforms. Additionally, the rise of quantitative radiomics and texture analysis workflows for oncology and neurology imaging is creating demand for solutions that can store, process, and mine high-dimensional feature sets at scale.
“The cardiology segment is estimated to hold the largest share of the enterprise imaging IT market in 2024, by therapeutic area.”
Based on therapeutic area, the enterprise imaging IT market is segmented into neurology, cardiology, oncology, orthopedics, and other therapeutic areas. The cardiology segment held the largest share in 2024 due to the surge in CT-derived fractional flow reserve (FFR CT) workflows, which require seamless integration of computational models and high-fidelity CT archives. The rapid expansion of hybrid cath lab/OR suites is driving the demand for enterprise viewers that can overlay 3D vessel reconstructions in real time during transcatheter valve and structural interventions. New CPT codes for AI-quantified ejection fraction and chamber volumetrics are also incentivizing hospitals to deploy platforms with built-in cardiac analytics. Additionally, the proliferation of wearable ECG and implantable device data streams is pushing cardiology departments to adopt enterprise solutions that fuse multi source signals with imaging studies for comprehensive cardiac risk stratification.
“The Asia Pacific region is expected to register the highest growth rate in the enterprise imaging IT market during the forecast period.”
The global enterprise imaging IT market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Asia Pacific is expected to register the highest growth for enterprise imaging IT in the forecast period. Factors such as India’s National Digital Health Mission integrating imaging data into its Health Locker for unified patient records, the rise of medical tourism hubs in Malaysia and Thailand demanding seamless cross border image exchange, public–private partnerships deploying mobile CT and MRI units in rural China, and the explosive uptake of low cost, AI powered handheld ultrasound devices in South Korea and India are all fueling Asia Pacific’s rapid enterprise imaging IT adoption.
The breakdown of primary participants is as mentioned below:
• By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation: C-level Executives (44%), Directors (31%), and Others (25%)
• By Region: North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)
Key Players
The prominent players in this market are Agfa-Gevaert Group (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Intelerad (Canada), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), INFINITT Healthcare Co., Ltd. (South Korea), Novarad (US), Mach7 Technologies (US), Hermes Medical Solutions (Sweden), Konica Minolta, Inc. (Japan), BridgeHead Software Ltd. (England), Sclmage, Inc. (US), VISUS Health IT GmbH (Germany), Dicom Systems, Inc. (US), PostDICOM (Netherlands), Qaelum (Belgium), AdvaHealth Solutions (Singapore), PaxeraHealth (US), and Rad AI (US). Players adopted organic and inorganic growth strategies such as solution launches, enhancements, and upgrades; collaborations; partnerships; acquisitions; agreements; and expansions to increase their offerings, cater to customers' unmet needs, increase their profitability, and expand their presence in the global market.
Research Coverage
• The report studies the enterprise imaging IT market based on function, modality, application, offering, deployment mode, therapeutic area, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micromarkets with respect to their growth trends, prospects, and contributions to the total enterprise imaging IT market.
• The report forecasts the revenue of market segments with respect to five major regions.
Reasons to Buy the Report
The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.
This report provides insights into the following pointers:
Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enterprise imaging IT market.
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the enterprise imaging IT market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of enterprise imaging IT solutions across regions.
Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the enterprise imaging IT market.
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the enterprise imaging IT market.
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 37
TABLE 2 FACTOR ANALYSIS 49
TABLE 3 RISK ASSESSMENT: ENTERPRISE IMAGING IT MARKET 54
TABLE 4 ENTERPRISE IMAGING IT MARKET: IMPACT ANALYSIS 65
TABLE 5 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011–2024 71
TABLE 6 ENTERPRISE IMAGING IT MARKET: ROLE IN ECOSYSTEM 82
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA 94
TABLE 13 REGULATORY SCENARIO OF EUROPE 95
TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC 96
TABLE 15 REGULATORY SCENARIO OF LATIN AMERICA 97
TABLE 16 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 97
TABLE 17 INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS,
BY FUNCTION (2024) 99
TABLE 18 INDICATIVE PRICING FOR ENTERPRISE IT IMAGING SOLUTIONS, BY REGION (2024) 100
TABLE 19 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 101
TABLE 20 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR ENTERPRISE IMAGING IT MARKET 104
TABLE 21 ENTERPRISE IMAGING IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS 106
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE END USERS (%) 107
TABLE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS 108
TABLE 24 UNMET NEEDS IN ENTERPRISE IMAGING IT MARKET 109
TABLE 25 END-USER EXPECTATIONS IN ENTERPRISE IMAGING IT MARKET 110
TABLE 26 ENTERPRISE IMAGING IT MARKET: KEY CONFERENCES & EVENTS, 2025–2026 111
TABLE 27 CASE STUDY 1: ENHANCING IMAGING EFFICIENCY & SECURITY WITH SECTRA’S AUTOMATED MULTIMEDIA WORKFLOW 112
TABLE 28 CASE STUDY 2: ENTERPRISE IMAGING CONSOLIDATION AT PIEDMONT HEALTHCARE WITH HYLAND VNA 113
TABLE 29 CASE STUDY 3: ENTERPRISE-WIDE IMAGING UNIFICATION WITH GE’S EDISON DATALOGUE AT A LEADING MEDICAL CENTER 113
TABLE 30 US-ADJUSTED RECIPROCAL TARIFF RATES 124
TABLE 31 ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 129
TABLE 32 VENDOR NEUTRAL ARCHIVES (VNA) OFFERED BY KEY MARKET PLAYERS 130
TABLE 33 ENTERPRISE IMAGING IT MARKET FOR VENDOR NEUTRAL ARCHIVES (VNA),
BY REGION, 2023–2030 (USD MILLION) 130
TABLE 34 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) OFFERED
BY KEY MARKET PLAYERS 132
TABLE 35 ENTERPRISE IMAGING IT MARKET FOR PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2023–2030 (USD MILLION) 132
TABLE 36 IMAGE EXCHANGE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 133
TABLE 37 ENTERPRISE IMAGING IT MARKET FOR IMAGE EXCHANGE, BY REGION,
2023–2030 (USD MILLION) 134
TABLE 38 UNIVERSAL VIEWERS OFFERED BY KEY MARKET PLAYERS 135
TABLE 39 ENTERPRISE IMAGING IT MARKET FOR UNIVERSAL VIEWERS, BY REGION,
2023–2030 (USD MILLION) 135
TABLE 40 WORKFLOW ORCHESTRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 136
TABLE 41 ENTERPRISE IMAGING IT MARKET FOR WORKFLOW ORCHESTRATION, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 42 ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 138
TABLE 43 ENTERPRISE IMAGING IT MARKET FOR ANALYTICS, BY REGION,
2023–2030 (USD MILLION) 138
TABLE 44 ENTERPRISE IMAGING IT MARKET FOR OTHER FUNCTIONS, BY REGION,
2023–2030 (USD MILLION) 139
TABLE 45 ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 141
TABLE 46 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 47 ENTERPRISE IMAGING IT MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 48 ENTERPRISE IMAGING IT MARKET FOR CLINICAL RESEARCH APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 144
TABLE 49 ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2023–2030 (USD MILLION) 146
TABLE 50 ENTERPRISE IMAGING IT MARKET FOR X-RAY, BY REGION,
2023–2030 (USD MILLION) 147
TABLE 51 ENTERPRISE IMAGING IT MARKET FOR MRI, BY REGION,
2023–2030 (USD MILLION) 149
TABLE 52 ENTERPRISE IMAGING IT MARKET FOR CT, BY REGION,
2023–2030 (USD MILLION) 150
TABLE 53 ENTERPRISE IMAGING IT MARKET FOR ULTRASOUND, BY REGION,
2023–2030 (USD MILLION) 151
TABLE 54 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,
2023–2030 (USD MILLION) 152
TABLE 55 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY REGION,
2023–2030 (USD MILLION) 153
TABLE 56 ENTERPRISE IMAGING IT MARKET FOR PET, BY REGION,
2023–2030 (USD MILLION) 154
TABLE 57 ENTERPRISE IMAGING IT MARKET FOR SPECT, BY REGION,
2023–2030 (USD MILLION) 154
TABLE 58 ENTERPRISE IMAGING IT MARKET FOR ENDOSCOPY, BY REGION,
2023–2030 (USD MILLION) 155
TABLE 59 ENTERPRISE IMAGING IT MARKET FOR MAMMOGRAPHY, BY REGION,
2023–2030 (USD MILLION) 156
TABLE 60 ENTERPRISE IMAGING IT MARKET FOR FLUOROSCOPY, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 61 ENTERPRISE IMAGING IT MARKET FOR ECHOCARDIOGRAPHY, BY REGION,
2023–2030 (USD MILLION) 159
TABLE 62 ENTERPRISE IMAGING IT MARKET FOR OTHER MODALITIES, BY REGION,
2023–2030 (USD MILLION) 160
TABLE 63 ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2023–2030 (USD MILLION) 162
TABLE 64 ENTERPRISE IMAGING IT MARKET FOR SOFTWARE, BY REGION,
2023–2030 (USD MILLION) 163
TABLE 65 ENTERPRISE IMAGING IT MARKET FOR SERVICES, BY REGION,
2023–2030 (USD MILLION) 164
TABLE 66 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 166
TABLE 67 ENTERPRISE IMAGING IT MARKET FOR ON-PREMISES SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 167
TABLE 68 ENTERPRISE IMAGING IT MARKET FOR CLOUD-BASED SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 168
TABLE 69 ENTERPRISE IMAGING IT MARKET FOR HYBRID SOLUTIONS, BY REGION,
2023–2030 (USD MILLION) 169
TABLE 70 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 171
TABLE 71 ENTERPRISE IMAGING IT MARKET FOR NEUROLOGY, BY REGION,
2023–2030 (USD MILLION) 172
TABLE 72 ENTERPRISE IMAGING IT MARKET FOR CARDIOLOGY, BY REGION,
2023–2030 (USD MILLION) 173
TABLE 73 ENTERPRISE IMAGING IT MARKET FOR ONCOLOGY, BY REGION,
2023–2030 (USD MILLION) 175
TABLE 74 ENTERPRISE IMAGING IT MARKET FOR ORTHOPEDICS, BY REGION,
2023–2030 (USD MILLION) 176
TABLE 75 ENTERPRISE IMAGING IT MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION) 176
TABLE 76 ENTERPRISE IMAGING IT MARKET, FOR END USER, 2023–2030 (USD MILLION) 178
TABLE 77 ENTERPRISE IMAGING IT MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 179
TABLE 78 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC CENTERS, BY REGION,
2023–2030 (USD MILLION) 180
TABLE 79 ENTERPRISE IMAGING IT MARKET FOR CLINICS & OUTPATIENT SETTINGS,
BY REGION, 2023–2030 (USD MILLION) 181
TABLE 80 ENTERPRISE IMAGING IT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 182
TABLE 81 ENTERPRISE IMAGING IT MARKET FOR MEDTECH COMPANIES, BY REGION,
2023–2030 (USD MILLION) 183
TABLE 82 ENTERPRISE IMAGING IT MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2023–2030 (USD MILLION) 185
TABLE 83 ENTERPRISE IMAGING IT MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 186
TABLE 84 ENTERPRISE IMAGING IT MARKET, BY REGION, 2023–2030 (USD MILLION) 188
TABLE 85 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 190
TABLE 86 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 190
TABLE 87 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 191
TABLE 88 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 89 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 192
TABLE 90 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 192
TABLE 91 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 192
TABLE 92 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 193
TABLE 93 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 193
TABLE 94 US: KEY MACROINDICATORS 195
TABLE 95 US: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 195
TABLE 96 US: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2023–2030 (USD MILLION) 196
TABLE 97 US: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 98 US: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 197
TABLE 99 US: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2023–2030 (USD MILLION) 197
TABLE 100 US: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 197
TABLE 101 US: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 198
TABLE 102 US: ENTERPRISE IMAGING IT MARKET, BY END USER, 2023–2030 (USD MILLION) 198
TABLE 103 CANADA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 200
TABLE 104 CANADA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 200
TABLE 105 CANADA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 106 CANADA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 201
TABLE 107 CANADA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 201
TABLE 108 CANADA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 202
TABLE 109 CANADA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 202
TABLE 110 CANADA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 203
TABLE 111 EUROPE: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 204
TABLE 112 EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 204
TABLE 113 EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 205
TABLE 114 EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 115 EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 206
TABLE 116 EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 206
TABLE 117 EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 206
TABLE 118 EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 207
TABLE 119 EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 207
TABLE 120 GERMANY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 209
TABLE 121 GERMANY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 209
TABLE 122 GERMANY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 123 GERMANY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 210
TABLE 124 GERMANY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 210
TABLE 125 GERMANY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 211
TABLE 126 GERMANY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 211
TABLE 127 GERMANY: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 212
TABLE 128 UK: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 213
TABLE 129 UK: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2023–2030 (USD MILLION) 213
TABLE 130 UK: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 131 UK: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 214
TABLE 132 UK: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2023–2030 (USD MILLION) 214
TABLE 133 UK: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 215
TABLE 134 UK: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 215
TABLE 135 UK: ENTERPRISE IMAGING IT MARKET, BY END USER, 2023–2030 (USD MILLION) 216
TABLE 136 FRANCE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 217
TABLE 137 FRANCE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 217
TABLE 138 FRANCE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 139 FRANCE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 218
TABLE 140 FRANCE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 218
TABLE 141 FRANCE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 219
TABLE 142 FRANCE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 219
TABLE 143 FRANCE: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 220
TABLE 144 ITALY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 221
TABLE 145 ITALY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 221
TABLE 146 ITALY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,
2023–2030 (USD MILLION) 222
TABLE 147 ITALY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 222
TABLE 148 ITALY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 222
TABLE 149 ITALY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 223
TABLE 150 ITALY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 223
TABLE 151 ITALY: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 224
TABLE 152 SPAIN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 225
TABLE 153 SPAIN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 225
TABLE 154 SPAIN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 155 SPAIN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 226
TABLE 156 SPAIN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 226
TABLE 157 SPAIN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 227
TABLE 158 SPAIN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 227
TABLE 159 SPAIN: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 228
TABLE 160 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 229
TABLE 161 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 229
TABLE 162 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 163 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 230
TABLE 164 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 230
TABLE 165 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 231
TABLE 166 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 231
TABLE 167 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 232
TABLE 168 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 235
TABLE 169 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 235
TABLE 170 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 236
TABLE 171 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 236
TABLE 172 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 237
TABLE 173 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 237
TABLE 174 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 237
TABLE 175 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 238
TABLE 176 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 238
TABLE 177 CHINA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 239
TABLE 178 CHINA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 240
TABLE 179 CHINA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 180 CHINA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 241
TABLE 181 CHINA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 241
TABLE 182 CHINA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 241
TABLE 183 CHINA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 242
TABLE 184 CHINA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 242
TABLE 185 JAPAN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 244
TABLE 186 JAPAN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 244
TABLE 187 JAPAN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 188 JAPAN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 245
TABLE 189 JAPAN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 245
TABLE 190 JAPAN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 246
TABLE 191 JAPAN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 246
TABLE 192 JAPAN: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 247
TABLE 193 INDIA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 248
TABLE 194 INDIA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 248
TABLE 195 INDIA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 196 INDIA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 249
TABLE 197 INDIA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 249
TABLE 198 INDIA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 250
TABLE 199 INDIA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 250
TABLE 200 INDIA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 251
TABLE 201 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 252
TABLE 202 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 252
TABLE 203 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 204 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 253
TABLE 205 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 253
TABLE 206 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 254
TABLE 207 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 254
TABLE 208 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 255
TABLE 209 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 256
TABLE 210 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 256
TABLE 211 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 257
TABLE 212 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 213 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 258
TABLE 214 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 258
TABLE 215 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 258
TABLE 216 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 259
TABLE 217 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 259
TABLE 218 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 260
TABLE 219 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 261
TABLE 220 BRAZIL: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 221 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 262
TABLE 222 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 262
TABLE 223 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 262
TABLE 224 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 263
TABLE 225 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 263
TABLE 226 MEXICO: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 265
TABLE 227 MEXICO: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 265
TABLE 228 MEXICO: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 229 MEXICO: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 266
TABLE 230 MEXICO: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 266
TABLE 231 MEXICO: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2023–2030 (USD MILLION) 267
TABLE 232 MEXICO: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 267
TABLE 233 MEXICO: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 268
TABLE 234 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 269
TABLE 235 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 269
TABLE 236 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 237 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270
TABLE 238 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 270
TABLE 239 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 271
TABLE 240 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 271
TABLE 241 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 272
TABLE 242 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY REGION,
2023–2030 (USD MILLION) 273
TABLE 243 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 274
TABLE 244 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 274
TABLE 245 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 246 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 275
TABLE 247 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 275
TABLE 248 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 276
TABLE 249 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 276
TABLE 250 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 277
TABLE 251 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,
2023–2030 (USD MILLION) 278
TABLE 252 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY MODALITY,
2023–2030 (USD MILLION) 279
TABLE 253 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 254 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 280
TABLE 255 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY OFFERING,
2023–2030 (USD MILLION) 280
TABLE 256 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 280
TABLE 257 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 281
TABLE 258 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY END USER,
2023–2030 (USD MILLION) 281
TABLE 259 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY FUNCTION, 2023–2030 (USD MILLION) 282
TABLE 260 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY MODALITY, 2023–2030 (USD MILLION) 283
TABLE 261 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 262 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 284
TABLE 263 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY OFFERING, 2023–2030 (USD MILLION) 284
TABLE 264 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 284
TABLE 265 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 285
TABLE 266 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,
BY END USER, 2023–2030 (USD MILLION) 285
TABLE 267 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET, JANUARY 2022–JUNE 2025 287
TABLE 268 ENTERPRISE IMAGING IT MARKET: DEGREE OF COMPETITION 292
TABLE 269 ENTERPRISE IMAGING IT MARKET: REGION FOOTPRINT 296
TABLE 270 ENTERPRISE IMAGING IT MARKET: FUNCTION FOOTPRINT 297
TABLE 271 ENTERPRISE IMAGING IT MARKET: APPLICATION FOOTPRINT 298
TABLE 272 ENTERPRISE IMAGING IT MARKET: THERAPEUTIC AREA FOOTPRINT 299
TABLE 273 ENTERPRISE IMAGING IT MARKET: DEPLOYMENT MODE FOOTPRINT 300
TABLE 274 ENTERPRISE IMAGING IT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 303
TABLE 275 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF
KEY EMERGING PLAYERS/STARTUPS, BY REGION 303
TABLE 276 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING
OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION 304
TABLE 277 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING
OF KEY EMERGING PLAYERS/STARTUPS, BY THERAPEUTIC AREA 304
TABLE 278 ENTERPRISE IMAGING IT MARKET: SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022–JUNE 2025 307
TABLE 279 ENTERPRISE IMAGING IT MARKET: DEALS, JANUARY 2022–JUNE 2025 308
TABLE 280 ENTERPRISE IMAGING IT MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 309
TABLE 281 AGFA-GEVAERT GROUP: COMPANY OVERVIEW 310
TABLE 282 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED 311
TABLE 283 AGFA-GEVAERT GROUP: DEALS, JANUARY 2022–JUNE 2025 313
TABLE 284 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 315
TABLE 285 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 317
TABLE 286 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–JUNE 2025 318
TABLE 287 GE HEALTHCARE: COMPANY OVERVIEW 320
TABLE 288 GE HEALTHCARE: SOLUTIONS OFFERED 321
TABLE 289 GE HEALTHCARE: SOLUTION LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 322
TABLE 290 GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 323
TABLE 291 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 325
TABLE 292 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 326
TABLE 293 KONINKLIJKE PHILIPS N.V.: SOLUTION LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 328
TABLE 294 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JUNE 2025 329
TABLE 295 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JUNE 2025 329
TABLE 296 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 331
TABLE 297 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED 332
TABLE 298 SIEMENS HEALTHINEERS AG: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025 335
TABLE 299 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–JUNE 2025 335
TABLE 300 OPTUM, INC.: COMPANY OVERVIEW 337
TABLE 301 OPTUM, INC.: SOLUTIONS OFFERED 338
TABLE 302 OPTUM, INC.: DEALS, JANUARY 2022–JUNE 2025 340
TABLE 303 SECTRA AB: COMPANY OVERVIEW 342
TABLE 304 SECTRA AB: SOLUTIONS OFFERED 344
TABLE 305 SECTRA AB: SOLUTION LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2025 346
TABLE 306 SECTRA AB: DEALS, JANUARY 2022–JUNE 2025 347
TABLE 307 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 348
TABLE 308 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED 350
TABLE 309 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–JUNE 2025 351
TABLE 310 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS,
JANUARY 2022–JUNE 2025 351
TABLE 311 MERATIVE: COMPANY OVERVIEW 352
TABLE 312 MERATIVE: SOLUTIONS OFFERED 352
TABLE 313 MERATIVE: DEALS, JANUARY 2022–JUNE 2025 353
TABLE 314 MERATIVE: EXPANSIONS, JANUARY 2022–JUNE 2025 353
TABLE 315 PRO MEDICUS, LTD.: COMPANY OVERVIEW 354
TABLE 316 PRO MEDICUS, LTD.: SOLUTIONS OFFERED 356
TABLE 317 PRO MEDICUS, LTD.: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025 357
TABLE 318 PRO MEDICUS, LTD.: DEALS, JANUARY 2022–JUNE 2025 357
TABLE 319 INTELERAD MEDICAL SYSTEMS INCORPORATED: COMPANY OVERVIEW 358
TABLE 320 INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTIONS OFFERED 358
TABLE 321 INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTION LAUNCHES,
JANUARY 2022–JUNE 2025 360
TABLE 322 INTELERAD: DEALS, JANUARY 2022–JUNE 2025 360
TABLE 323 HYLAND SOFTWARE, INC.: COMPANY OVERVIEW 362
TABLE 324 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED 362
TABLE 325 HYLAND SOFTWARE, INC.: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025 363
TABLE 326 HYLAND SOFTWARE, INC.: DEALS, JANUARY 2022–JUNE 2025 363
TABLE 327 INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW 365
TABLE 328 INFINITT HEALTHCARE CO., LTD.: SOLUTIONS OFFERED 366
TABLE 329 INFINITT HEALTHCARE CO., LTD.: SOLUTION LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 366
TABLE 330 INFINITT HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–JUNE 2025 367
TABLE 331 NOVARAD: COMPANY OVERVIEW 368
TABLE 332 NOVARAD: SOLUTIONS OFFERED 368
TABLE 333 MACH7 TECHNOLOGIES: COMPANY OVERVIEW 370
TABLE 334 MACH7 TECHNOLOGIES: SOLUTIONS OFFERED 372
TABLE 335 MACH7 TECHNOLOGIES: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025 373
TABLE 336 MACH7 TECHNOLOGIES: DEALS, JANUARY 2022–JUNE 2025 373
TABLE 337 HERMES MEDICAL SOLUTIONS: COMPANY OVERVIEW 374
TABLE 338 HERMES MEDICAL SOLUTIONS: SOLUTIONS OFFERED 374
TABLE 339 HERMES MEDICAL SOLUTIONS: SOLUTION LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022–JUNE 2025 376
TABLE 340 HERMES MEDICAL SOLUTIONS: DEALS, JANUARY 2022–JUNE 2025 377
TABLE 341 KONICA MINOLTA, INC.: COMPANY OVERVIEW 378
TABLE 342 KONICA MINOLTA, INC.: SOLUTIONS OFFERED 379
TABLE 343 KONICA MINOLTA, INC.: SOLUTION LAUNCHES & ENHANCEMENTS,
JANUARY 2022–JUNE 2025 381
TABLE 344 KONICA MINOLTA, INC.: DEALS, JANUARY 2022–JUNE 2025 381
TABLE 345 BRIDGEHEAD SOFTWARE LTD.: COMPANY OVERVIEW 383
TABLE 346 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED 383
TABLE 347 BRIDGEHEAD SOFTWARE LTD.: DEALS, JANUARY 2022–JUNE 2025 384
TABLE 348 SCIMAGE, INC.: COMPANY OVERVIEW 385
TABLE 349 SCIMAGE, INC.: SOLUTIONS OFFERED 385
TABLE 350 SCIMAGE, INC.: SOLUTION LAUNCHES, JANUARY 2022–JUNE 2025 386
TABLE 351 SCIMAGE, INC.: DEALS, JANUARY 2022–JUNE 2025 387
TABLE 352 VISUS HEALTH IT GMBH: COMPANY OVERVIEW 388
TABLE 353 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED 388
TABLE 354 VISUS HEALTH IT GMBH: SOLUTION ENHANCEMENTS, JANUARY 2022–JUNE 2025 389
FIGURE 1 ENTERPRISE IMAGING IT MARKET SEGMENTATION & REGIONAL SCOPE 34
FIGURE 2 RESEARCH DESIGN 39
FIGURE 3 PRIMARY SOURCES 41
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 44
FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION 46
FIGURE 8 ENTERPRISE IMAGING IT MARKET: REVENUE ESTIMATION APPROACH 46
FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON ENTERPRISE IMAGING IT 48
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 50
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
FIGURE 12 TOP-DOWN APPROACH 51
FIGURE 13 DATA TRIANGULATION METHODOLOGY 52
FIGURE 14 ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION) 55
FIGURE 15 ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION) 56
FIGURE 16 ENTERPRISE IMAGING IT MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 57
FIGURE 17 ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 57
FIGURE 18 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,
2025 VS. 2030 (USD MILLION) 58
FIGURE 19 ENTERPRISE IMAGING IT MARKET: GEOGRAPHICAL SNAPSHOT 59
FIGURE 20 RISING IMAGING VOLUMES TO DRIVE GROWTH IN ENTERPRISE IMAGING IT MARKET 60
FIGURE 21 DIAGNOSTIC APPLICATIONS IN NORTH AMERICA ACCOUNTED FOR
LARGEST MARKET SHARE IN 2024 61
FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 62
FIGURE 23 GROWTH RATES OF EMERGING ECONOMIES TO BE HIGHER THAN THOSE OF DEVELOPED MARKETS DURING FORECAST PERIOD 63
FIGURE 24 ENTERPRISE IMAGING IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 69
FIGURE 26 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2009–2024 70
FIGURE 27 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 70
FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
FIGURE 29 ENTERPRISE IMAGING IT MARKET: ECOSYSTEM ANALYSIS 81
FIGURE 30 ENTERPRISE IMAGING IT MARKET: SUPPLY CHAIN ANALYSIS (2024) 84
FIGURE 31 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 101
FIGURE 32 PATENT PUBLICATION TRENDS IN ENTERPRISE IMAGING IT MARKET, 2015–2025 103
FIGURE 33 JURISDICTION AND TOP APPLICANT ANALYSIS FOR ENTERPRISE
IMAGING IT MARKET 104
FIGURE 34 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERPRISE IMAGING IT MARKET (JANUARY 2015 TO JULY 2025) 105
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 107
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE END USERS 108
FIGURE 38 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING ENTERPRISE
IMAGING IT ACROSS INDUSTRIES 117
FIGURE 39 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 120
FIGURE 40 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET SNAPSHOT 189
FIGURE 41 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET SNAPSHOT 234
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET,
2020–2024 (USD MILLION) 290
FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING
IT MARKET (2024) 291
FIGURE 44 ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 294
FIGURE 45 ENTERPRISE IMAGING IT MARKET: COMPANY FOOTPRINT 295
FIGURE 46 ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 302
FIGURE 47 EV/EBITDA OF KEY VENDORS 305
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 305
FIGURE 49 ENTERPRISE IMAGING IT MARKET: BRAND/SOFTWARE COMPARITIVE ANALYSIS 306
FIGURE 50 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2024) 311
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023) 316
FIGURE 52 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 321
FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 326
FIGURE 54 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 332
FIGURE 55 OPTUM, INC.: COMPANY SNAPSHOT (2024) 338
FIGURE 56 SECTRA AB: COMPANY SNAPSHOT (2023) 343
FIGURE 57 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2024) 349
FIGURE 58 PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2024) 355
FIGURE 59 INFINITT HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024) 365
FIGURE 60 MACH7 TECHNOLOGIES: COMPANY SNAPSHOT (2023) 371
FIGURE 61 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2024) 379